Industry
Health Care
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Health Care
... Autolus Announces Pricing of Initial Public Offering LONDON - 22 June, 2018 - ...
... Cambridge, Massachusetts-based Avrobio, a developer of gene therapies for rare diseases, has raised $99.7 million ...
... Magenta Therapeutics, Inc. , a clinical-stage biotechnology company developing novel medicines to bring the ...
... EDT ORIGINAL ANNOUNCEMENT [Text] NEWTOWN, Pa., June 18, 2018 -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on ...
... shares of common stock will be issued in the offering. In addition, Achieve has granted the underwriters a 45-day option to purchase up to 450,000 ...
... Calliditas has filed to raise SEK 650 million ($75 million) through an IPO ...
... ARE YOU KIDDING: For the love of God. The dust from the Theranos saga hasn't even settled yet, but it appears that founder Elizabeth Holmes ...
... venture funding and was approved by the FDA after two failed attempts. Valeant agreed to buy Sprout for $1 billion in cash in August 2015. ...
... MORRIS PLAINS, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) ("Immunomedics" or the "Company"), a leading biopharmaceutical company in the area ...
... Trovagene, Inc. (NASDAQ: TROV), a clinical-stage oncology therapeutics company, developing targeted therapeutics for the ...
Subscribe now for full coverage on IPOs in Health Care
Start My Free Trial